These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 27317442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections.
    Ortiz-Covarrubias A, Fang E, Prokocimer PG, Flanagan SD, Zhu X, Cabré-Márquez JF, Tanaka T, Passarell J, Fiedler-Kelly J, Nannini EC.
    Braz J Infect Dis; 2016; 20(2):184-92. PubMed ID: 26859064
    [Abstract] [Full Text] [Related]

  • 6. Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.
    Douros A, Grabowski K, Stahlmann R.
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1849-59. PubMed ID: 26457865
    [Abstract] [Full Text] [Related]

  • 7. Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
    Moran GJ, Fang E, Corey GR, Das AF, De Anda C, Prokocimer P.
    Lancet Infect Dis; 2014 Aug; 14(8):696-705. PubMed ID: 24909499
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid.
    Flanagan S, Fang E, Muñoz KA, Minassian SL, Prokocimer PG.
    Pharmacotherapy; 2014 Sep; 34(9):891-900. PubMed ID: 24989138
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
    Bradley JS, Flanagan SD, Arrieta AC, Jacobs R, Capparelli E, Prokocimer P.
    Pediatr Infect Dis J; 2016 Jun; 35(6):628-33. PubMed ID: 26910588
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug.
    Flanagan SD, Bien PA, Muñoz KA, Minassian SL, Prokocimer PG.
    Pharmacotherapy; 2014 Mar; 34(3):240-50. PubMed ID: 23926058
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.
    Lv X, Alder J, Li L, O'Riordan W, Rybak MJ, Ye H, Zhang R, Zhang Z, Zhu X, Wilcox MH.
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988146
    [Abstract] [Full Text] [Related]

  • 15. Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.
    Burdette SD, Trotman R.
    Clin Infect Dis; 2015 Oct 15; 61(8):1315-21. PubMed ID: 26105167
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate in Elderly Subjects.
    Flanagan SD, Minassian SL, Prokocimer P.
    Clin Pharmacol Drug Dev; 2018 Sep 15; 7(7):788-794. PubMed ID: 29319932
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects.
    Chen R, Shen K, Chang X, Tanaka T, Li L, Hu P.
    Clin Ther; 2016 Aug 15; 38(8):1869-79. PubMed ID: 27461846
    [Abstract] [Full Text] [Related]

  • 18. Lack of neuropathological changes in rats administered tedizolid phosphate for nine months.
    Schlosser MJ, Hosako H, Radovsky A, Butt MT, Draganov D, Vija J, Oleson F.
    Antimicrob Agents Chemother; 2015 Jan 15; 59(1):475-81. PubMed ID: 25385101
    [Abstract] [Full Text] [Related]

  • 19. Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.
    Urbina O, Ferrández O, Espona M, Salas E, Ferrández I, Grau S.
    Drug Des Devel Ther; 2013 Jan 15; 7():243-65. PubMed ID: 23589680
    [Abstract] [Full Text] [Related]

  • 20. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
    Rybak JM, Marx K, Martin CA.
    Pharmacotherapy; 2014 Nov 15; 34(11):1198-208. PubMed ID: 25266820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.